U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839300) titled 'The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study' on Feb. 17.
Brief Summary: To determine the accuracy of serum NF-L and GFAP levels (ie the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D) a group of patients who suffer traumatic spinal fracture and/or dislocation of the spinal column but without neurologic injury will be enrolled as non-SCI spine trauma control participants.
Study Start Date: June 01, 2025
Study Type: OBSERVATIONAL
...